Methylprednisolone, IV Immunoglobulin, Tocilizumab, or Anakinra for Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS/MIS-C): Report From a Randomized, Controlled, Open-Label Platform Trial (Lancet Child and Adolescent Health)
